zonisamide has been researched along with Diabetic Cardiomyopathies in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, JH | 1 |
| Wu, Q | 1 |
| He, YX | 1 |
| Shen, QY | 1 |
| Rekep, M | 1 |
| Zhang, GP | 1 |
| Luo, JD | 1 |
| Xue, Q | 1 |
| Liu, YH | 1 |
1 other study available for zonisamide and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Zonisamide, an antiepileptic drug, alleviates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress.
Topics: Animals; Anticonvulsants; Apoptosis; Blood Glucose; Body Weight; Cardiomegaly; Diabetes Mellitus, Ty | 2021 |